
TECHNOLOGY
18 Feb 2026
Biotech firms are using cloud platforms to accelerate mRNA research while managing compliance, security, and rising costs

INSIGHTS
16 Feb 2026
A €6.9 million EU grant backs eTheRNA’s cancer vaccines and signals Europe’s long-term bet on mRNA oncology

REGULATORY
12 Feb 2026
Agency’s decision signals tougher trial standards for seasonal vaccine approvals as pandemic-era flexibility recedes

INNOVATION
11 Feb 2026
As saRNA advances in 2026, CPI’s RNA infrastructure is reinforcing the UK’s role in Europe’s evolving vaccine manufacturing landscape

PARTNERSHIPS
10 Feb 2026
Moderna and Recordati partner on an mRNA therapy for propionic acidemia, combining resources to accelerate development

MARKET TRENDS
5 Feb 2026
Big acquisitions and delivery breakthroughs signal mRNA’s shift from pandemic speed to precision therapies
A NEW APPROACH TO PLASMID DNA CHARACTERIZATION FOR IVT WITH SLALOM CHROMATOGRAPHY
Day 1: MONDAY, APRIL 27, 2026
09:10 - 09:35
WHAT 3,000 RNA PROJECTS REVEAL ABOUT ENGINEERING mRNA, saRNA, AND circRNA
Day 1: MONDAY, APRIL 27, 2026
09:40 - 10:05
ENHANCING mRNA–LNP DOWNSTREAM PROCESSING VIA SINGLE-PASS TANGENTIAL FLOW FILTRATION (SPTFF)
Day 1: MONDAY, APRIL 27, 2026
10:10 - 10:35
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.